Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACAIOTCMKTS:HCYTDOTCMKTS:RGIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACAISafeplus International$0.00$0.00▼$0.00N/A0.72105 shsN/AHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsRGINRegenicin$0.00$0.00▼$0.00N/AN/A35,003 shsN/A7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACAISafeplus International0.00%0.00%0.00%0.00%-20.00%HCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%RGINRegenicin0.00%0.00%0.00%0.00%-98.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACAISafeplus InternationalN/AN/AN/AN/AN/AN/AN/AN/AHCYTDH-CYTEN/AN/AN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACAISafeplus International 0.00N/AN/AN/AHCYTDH-CYTE 0.00N/AN/AN/ARGINRegenicin 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACAISafeplus InternationalN/AN/AN/AN/AN/AN/AHCYTDH-CYTE$1.61M0.32N/AN/A($31.45) per share-0.06RGINRegenicinN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACAISafeplus InternationalN/AN/A0.00N/AN/AN/AN/AN/AN/AHCYTDH-CYTE-$4.80MN/A0.00∞N/A-450.40%N/A-777.68%N/ARGINRegenicin-$640KN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACAISafeplus InternationalN/AN/AN/AN/AN/AHCYTDH-CYTEN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACAISafeplus InternationalN/AN/AN/AHCYTDH-CYTEN/A0.120.12RGINRegenicinN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACAISafeplus InternationalN/AHCYTDH-CYTEN/ARGINRegenicin0.01%Insider OwnershipCompanyInsider OwnershipACAISafeplus International4.02%HCYTDH-CYTE5.24%RGINRegenicinN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACAISafeplus International225.38 million24.36 millionNot OptionableHCYTDH-CYTE8258,000244,000Not OptionableRGINRegenicin3165.77 millionN/ANot OptionableHCYTD, ACAI, and RGIN HeadlinesRecent News About These CompaniesHistoryOctober 20, 2024 | npr.orgShaun Micallef's Origin OdysseyOctober 18, 2024 | sbs.com.auRegenicin, Inc. (RGIN)September 5, 2024 | finance.yahoo.comThe Cambridge World History of SlaveryAugust 20, 2024 | cambridge.orgThe Cambridge Ancient HistoryAugust 3, 2024 | cambridge.orgHow to watch State of Origin overseas: International broadcasters, TV channels, live streams, timesJuly 19, 2024 | sportingnews.comState of Origin: When and where is Origin in 2024?May 21, 2024 | sportingnews.comLGBT+ History Month - Teaching ResourcesMay 3, 2024 | bbc.co.ukHistory & TraditionApril 20, 2024 | smith.eduSevere cold front hits central, eastern regions; schools forced to delay start of new semesterFebruary 21, 2024 | globaltimes.cnPalworld map – all locations, regions, and points of interestFebruary 2, 2024 | pcgamesn.comAlexander boys fend off top challenger in Region 5January 30, 2024 | ajc.comJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'January 20, 2024 | foxnews.comJournal of the History of Economic ThoughtJanuary 7, 2024 | cambridge.orgHistory of computers: A brief timelineDecember 24, 2023 | livescience.comWATCH: Blue Origin successfully launches rocket in first flight since 2022 crashDecember 21, 2023 | wlwt.comBlue Origin successfully completes rocket mission more than a year after failed launchDecember 21, 2023 | nydailynews.comBlue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video)December 20, 2023 | space.comJeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 monthsDecember 20, 2023 | geekwire.comHistory of Walmart: Timeline and FactsDecember 9, 2023 | thestreet.comMedia Sentiment Over TimeHCYTD, ACAI, and RGIN Company DescriptionsSafeplus International OTCMKTS:ACAISafeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.H-CYTE OTCMKTS:HCYTD$2.02 -1.98 (-49.50%) As of 07/11/2022H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.Regenicin OTCMKTS:RGINRegenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
